I think this is the case, and it has been mentioned elsewhere in this thread. When I see a paper published that I am interested in, I have to fit it into the context what I already know about a field, the standards of the the journal its published in, sometimes the origin of the paper (some labs are much less sloppy than others), and other factors.
For a recent personal example, a company published a paper saying that if you give a pre-treat with 2 doses of a particular drug, you can avoid some genetic markers of inflammation that are in the bloodstream and kidneys. Well, I looked at the stimulus and ordered some of my own from a different manufacturer that was easier to obtain and gave it to some mice with and without pretreatment by their compound. Instead of looking at the genes they looked at, I looked at an uptick in a protein expected to be one step removed from the genes they showed a change in. Well I haven't exactly replicated their study, but I've replicated the core points: stimulus with a the same cytokine gives a response in a particular pathway and it either is or isn't mitigated by the drug or class of drugs they showed. Now, my study took 2 days less than theirs, but it worked well enough that I don't need to fret the particular details I did differently from them. If my study didn't work, I could either decide that the study isn't important to me if it didn't work my way or go back a step and try to match their exact reagents and methods.
So yes, I do think the news industry picks up stuff too quickly sometimes, but depending on the outlet, they tend to couch things in appropriate wiggle words (may show, might prove, could lead to, add evidence, etc).
For a recent personal example, a company published a paper saying that if you give a pre-treat with 2 doses of a particular drug, you can avoid some genetic markers of inflammation that are in the bloodstream and kidneys. Well, I looked at the stimulus and ordered some of my own from a different manufacturer that was easier to obtain and gave it to some mice with and without pretreatment by their compound. Instead of looking at the genes they looked at, I looked at an uptick in a protein expected to be one step removed from the genes they showed a change in. Well I haven't exactly replicated their study, but I've replicated the core points: stimulus with a the same cytokine gives a response in a particular pathway and it either is or isn't mitigated by the drug or class of drugs they showed. Now, my study took 2 days less than theirs, but it worked well enough that I don't need to fret the particular details I did differently from them. If my study didn't work, I could either decide that the study isn't important to me if it didn't work my way or go back a step and try to match their exact reagents and methods.
So yes, I do think the news industry picks up stuff too quickly sometimes, but depending on the outlet, they tend to couch things in appropriate wiggle words (may show, might prove, could lead to, add evidence, etc).